|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cai Y, Lyu T, Li H, Liu C, Xie K, Xu L, Li
W, Liu H, Zhu J, Lyu Y, et al: LncRNA CEBPA-DT promotes liver
cancer metastasis through DDR2/β-catenin activation via interacting
with hnRNPC. J Exp Clin Cancer Res. 41:3352022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ganesan P and Kulik LM: Hepatocellular
carcinoma: New developments. Clin Liver Dis. 27:85–102. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vogel A, Meyer T, Sapisochin G, Salem R
and Saborowski A: Hepatocellular carcinoma. Lancet. 400:1345–1362.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gilles HT, Garbutt T and Landrum J:
Hepatocellular carcinoma. Crit Care Nurs Clin North Am. 34:289–301.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou H, Hao X, Zhang P and He S: Noncoding
RNA mutations in cancer. Wiley Interdiscip Rev RNA. 14:e18122023.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Zhang X, You Z, Meng Y, Fan X,
Qiao G and Pang D: RNA atlas and competing endogenous RNA
regulation in tissue-derived exosomes from luminal B and
triple-negative breast cancer patients. Front Oncol.
13:11131152023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leng D, Yang Z, Sun H, Song C, Huang C, Ip
KU, Chen G, Deng CX, Zhang XD and Zhao Q: Comprehensive analysis of
tumor microenvironment reveals prognostic ceRNA network related to
immune infiltration in sarcoma. Clin Cancer Res. 29:3986–4001.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu Z, Yang G, Wang T, Gao D, Lin D and Liu
X: Comprehensive analysis of the Sorafenib-associated druggable
targets on differential gene expression and ceRNA network in
hepatocellular carcinoma. J Environ Pathol Toxicol Oncol. 42:47–60.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Qiu X, He Q, Fu X, Ji F and Tian X:
CCND1-associated ceRNA network reveal the critical pathway of
TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and
neck squamous cell carcinoma. Sci Rep. 13:118312023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Hu J, Guo D, Ma W, Zhang X, Zhang Z,
Lu G and He S: LncRNA SNHG5 promotes the proliferation and cancer
stem cell-like properties of HCC by regulating UPF1 and
Wnt-signaling pathway. Cancer Gene Ther. 29:1373–1383. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu Q, Wang H, Lei X, Ma Q, Zhao J, Sun W,
Guo C, Huang D and Xu Q: LncRNA ALKBH3-AS1 enhances ALKBH3 mRNA
stability to promote hepatocellular carcinoma cell proliferation
and invasion. J Cell Mol Med. 26:5292–5302. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang C, Yu H, Zheng Y, Feng W and Shen J:
lncRNA TINCR regulates proliferation and invasion of hepatocellular
carcinoma cells by regulating the miR-375/ATG7 axis. J Oncol.
2022:81324032022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Zhou Y, Gu C, Ming F and Zhang Y:
LncRNA SAMD12-AS1 suppresses proliferation and migration of
hepatocellular carcinoma via p53 signaling pathway. J Oncol.
2022:90963652022.PubMed/NCBI
|
|
15
|
Wei H, Xu Z, Chen L, Wei Q, Huang Z, Liu
G, Li W, Wang J, Tang Q and Pu J: Long non-coding RNA PAARH
promotes hepatocellular carcinoma progression and angiogenesis via
upregulating HOTTIP and activating HIF-1α/VEGF signaling. Cell
Death Dis. 13:1022022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni
A, Kamel IR, Cloyd JM and Pawlik TM: Management of hepatocellular
carcinoma: A review. JAMA Surg. 158:410–420. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Farzaneh M, Ghasemian M, Ghaedrahmati F,
Poodineh J, Najafi S, Masoodi T, Kurniawan D, Uddin S and
Azizidoost S: Functional roles of lncRNA-TUG1 in hepatocellular
carcinoma. Life Sci. 308:1209742022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pu J, Wang J, Wei H, Lu T, Wu X, Wu Y,
Shao Z, Luo C and Lu Y: lncRNA MAGI2-AS3 prevents the development
of HCC via recruiting KDM1A and promoting H3K4me2 Demethylation of
the RACGAP1 promoter. Mol Ther Nucleic Acids. 18:351–362. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kong XX, Yang X, Jiang WJ, Zhu M and Kong
LB: The long non-coding RNA AC006329.1 facilitates hepatocellular
carcinoma progression and metastasis by regulating
miR-127-5p/SHC3/ERK axis. J Hepatocell Carcinoma. 10:1085–1103.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yao J and Liu X: lncRNA PITPNA-AS1
promotes cell proliferation and metastasis in hepatocellular
carcinoma by upregulating PDGFD. Aging (Albany NY). 15:4071–4083.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Zhu Y, Ai X, Wan H, Jia W, Chu J,
Xu B, Kong X and Kong L: Long noncoding RNA 02027 inhibits
proliferation, migration and invasion of hepatocellular carcinoma
via miR-625-3p/PDLIM5 pathway. J Gene Med. 25:e34852023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Butt E, Howard CM and Raman D: LASP1 in
cellular signaling and gene expression: More than just a
cytoskeletal regulator. Cells. 11:38172022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duvall-Noelle N, Karwandyar A, Richmond A
and Raman D: LASP-1: A nuclear hub for the UHRF1-DNMT1-G9a-snail1
complex. Oncogene. 35:1122–1133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Niimi A, Limsirichaikul S, Kano K,
Mizutani Y, Takeuchi T, Sawangsri P, Tran DQ, Kawamoto Y and Suzuki
M: LASP1, CERS6, and actin form a ternary complex that promotes
cancer cell migration. Cancers (Basel). 15:27812023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ke S, Fang M, Li R, Wang J and Lu J:
Downregulation of long noncoding RNA breast cancer anti-estrogen
resistance 4 inhibits cell proliferation, invasion, and migration
in esophageal squamous cell carcinoma by regulating the
microRNA-181c-5p/LIM and SH3 protein 1 axis. Bioengineered.
13:12998–13010. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Herrmann AB, Müller ML, Orth MF, Müller
JP, Zernecke A, Hochhaus A, Ernst T, Butt E and Frietsch JJ:
Knockout of LASP1 in CXCR4 expressing CML cells promotes cell
persistence, proliferation and TKI resistance. J Cell Mol Med.
24:2942–2955. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan P, Liu J, Zhou R, Lin C, Wu K, Yang S,
Yang S, Zhou J, Xu L, Wang H and Zhao L: LASP1 interacts with
N-WASP to activate the Arp2/3 complex and facilitate colorectal
cancer metastasis by increasing tumour budding and worsening the
pattern of invasion. Oncogene. 39:5743–5755. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen N, Han X, Bai X, Yin B and Wang Y:
LASP1 induces colorectal cancer proliferation and invasiveness
through Hippo signaling and Nanog mediated EMT. Am J Transl Res.
12:6490–6500. 2020.PubMed/NCBI
|
|
32
|
Li ZX, Zheng ZQ, Yang PY, Lin L, Zhou GQ,
Lv JW, Zhang LL, Chen F, Li YQ, Wu CF, et al: WTAP-mediated m(6)A
modification of lncRNA DIAPH1-AS1 enhances its stability to
facilitate nasopharyngeal carcinoma growth and metastasis. Cell
Death Differ. 29:1137–1151. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou L, Zhang L, Guan X, Dong YI and Liu
T: Long noncoding RNA PPP1R14B-AS1 imitates microRNA-134-3p to
facilitate breast cancer progression by upregulating LIM and SH3
protein 1. Oncol Res. 29:251–262. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen X, Zhao S, Li Q, Xu C, Yu Y and Ge H:
LncRNA NEAT1 knockdown inhibits retinoblastoma progression by
miR-3619-5p/LASP1 axis. Front Genet. 11:5741452020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dejima T, Imada K, Takeuchi A, Shiota M,
Leong J, Tombe T, Tam K, Fazli L, Naito S, Gleave ME and Ong CJ:
Suppression of LIM and SH3 domain protein 1 (LASP1) negatively
regulated by androgen receptor delays castration resistant prostate
cancer progression. Prostate. 77:309–320. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou R, Shao Z, Liu J, Zhan W, Gao Q, Pan
Z, Wu L, Xu L, Ding Y and Zhao L: COPS5 and LASP1 synergistically
interact to downregulate 14-3-3σ expression and promote colorectal
cancer progression via activating PI3K/AKT pathway. Int J Cancer.
142:1853–1864. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Butt E, Ebbing J, Bubendorf L and Ardelt
P: Influence of hematuria and infection on diagnostic accuracy of
urinary LASP1: A new biomarker for bladder carcinoma. Biomark Med.
11:347–357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Q, Wu K, Qin X, Yu Y, Wang X and Wei
K: LASP1 promotes proliferation, metastasis, invasion in head and
neck squamous cell carcinoma and through direct interaction with
HSPA1A. J Cell Mol Med. 24:1626–1639. 2020. View Article : Google Scholar : PubMed/NCBI
|
